Skip to main content
. 2021 Mar 12;39(5):549–561. doi: 10.1007/s40273-021-01002-z
This is the first EQ-5D-5L valuation study in Egypt and in the Middle East and North Africa region.
The Egyptian tariff can be used as a scoring system for economic evaluations, to inform decision making, and to improve the quality of health technology assessment in the Egyptian healthcare system.
The availability of the Egyptian tariff will encourage health economists and clinicians to include quality-of-life questionnaires in clinical trials and implement cost-utility analysis and pharmacoeconomic modelling.